News
- 2025/09/19
- Noile-Immune’s President & CEO, Koji Tamada, MD, Ph.D. (Professor at Yamaguchi University Graduate School of Medicine), will give a lecture at “The 84th Annual Meeting of the Japanese Cancer Association (from Thursday, September 25 to Saturday, September 27 in Kanazawa).
- ・Date and time: Thursday, September 25, 2025, 12:50–15:20
・Venue： Room 1; Ishikawa Ongakudo, 2nd Floor “Concert Hall”
・Session: Hajime Okamoto Memorial Symposium
・Session Title: SS5 Exit-Oriented Drug Discovery Technology from Academia
・Lecture Title: SS5-3 Clinical development of next-generation CAR-T technologies originated from academic institutions
・Speaker: Koji Tamada MD, Ph.D. (Professor at Yamaguchi University Graduate School of Medicine)
Information on the 84th Annual Meeting of the Japanese Cancer Association is here.
- 2025/07/25
- A joint press conference was held at Ube City Hall in Yamaguchi Prefecture on July 23, 2025 regarding the collaborative support for the Noile-Immune’s project by Yamaguchi Prefecture and Ube City. (2025/8/22 update)
- Noile-Immune's project, “Social implementation of world's first treatment for solid tumors by CAR-T cell therapy with next-generation immune-enhancing technology and formation of a wide-area collaboration base for research and development” was adopted for subsidies by Yamaguchi Prefecture and Ube City. On Wednesday, July 23, 2025, a joint press conference was held at the Ube City Hall in Yamaguchi Prefecture.
Details of the press conference are being reported by various media coverages.
(The articles are written in Japanese only, so sorry for your inconvenience)
（NHK 2025/7/24）
Article in Japanese
（KRY山口放送: KRY News 2025/7/24）
Article in Japanese
（山口新聞（電子版）:Yamaguchi shimbun 2025/7/24）
Article in Japanese
（宇部日報: Ube Nippo 2025/7/24）
Article in Japanese
（毎日新聞: THE MAINICHI NEWSPAPERS 2025/7/25）
Article in Japanese
（YAB山口朝日放送: Yamaguchi Asahi Broadcasting 2025/8/21）
Article in Japanese